IO Biotech Inc (IOBT)

NASDAQ
Currency in USD
0.960
+0.037(+4.01%)
Closed·
After Hours
0.930-0.030(-3.125%)
·
IOBT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.8501.000
52 wk Range
0.6601.790
Key Statistics
Edit
Prev. Close
0.923
Open
0.93
Day's Range
0.85-1
52 wk Range
0.66-1.79
Volume
213.63K
Average Volume (3m)
162.74K
1-Year Change
-32.39%
Book Value / Share
0.71
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IOBT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9.000
Upside
+837.50%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

IO Biotech Company Profile

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company’s lead product candidate, IO102-IO103, which is designed to target immunosuppressive mechanisms mediated by Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.

Compare IOBT to Peers and Sector

Metrics to compare
IOBT
Peers
Sector
Relationship
P/E Ratio
−0.7x−1.9x−0.5x
PEG Ratio
−0.02−0.010.00
Price/Book
1.3x1.8x2.6x
Price / LTM Sales
-12.0x2.9x
Upside (Analyst Target)
-316.7%60.5%
Fair Value Upside
Unlock4.3%8.5%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 9.000
(+837.50% Upside)

Earnings

Latest Release
Mar 27, 2025
EPS / Forecast
-0.43 / -0.3125
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the IO Biotech (IOBT) Stock Price Today?

The IO Biotech stock price today is 0.96.

What Stock Exchange Does IO Biotech Trade On?

IO Biotech is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for IO Biotech?

The stock symbol for IO Biotech is "IOBT."

What Is the IO Biotech Market Cap?

As of today, IO Biotech market cap is 63.25M.

What is IO Biotech Earnings Per Share?

The IO Biotech EPS is -1.45.

What Is the Next IO Biotech Earnings Date?

IO Biotech will release its next earnings report on 18 May 2025.

From a Technical Analysis Perspective, Is IOBT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.